Canadian Pharmacists Journal最新文献

{"title":"Thanks to our 2019 reviewers","authors":"S. Abidi, J. Abma, Michelle Abraczinskas, Lisa Abuogi, Francesco Acciai, E. Adam, Margo E. Killham Adam, Zachary Adams, Sally Adams, William Adelman, O. Adetokunboh, N. Adler, Molly Adrian, Jon Agley, C. Baugh, Christine Agnew-Brune, W. Agras, E. Agudile, Aimalohi Ahonkai, Elsie Akwara, T. Alaqzam, Rachel Alinsky, Julia L. Allan, Chenoa Allen, David Allen, Carlos A. Almenara, Joanne D. Altman, K. Alvarez, Carmen Alvarez, Daniele Evelin Alves, Ilana Ambrogi, N. Ameenuddin, K. Amico, Sajeda Amin, S. Ammerman, Allan Andersen, Martin Anderson, Emily Ellen Anderson, S. Anderson, T. Andrasfay, Judy A. Andrews, J. Andrzejewski, Rachel A. Annunziato, Arash Anoshiravani, James Christopher Anthony, Joana Araújo, Steven R. Aragon, G. Arbanas, M. Arcinas, A. Thomas, T. Barnett, N. Barnett, L. Barnett, J. Barrington-Trimis, L. Barrios, Rachel Barry, Erin Barthel, R. Bartlett, Francisco I. Bastos, S. Basu, D. Batisky, P. Batterham, K. Bauer, L. Beach, E. Beatriz, J. Becasen, K. Beck, Inga Becker-Hebly, Kathleen R Beckm","doi":"10.1002/vzj2.20046","DOIUrl":"https://doi.org/10.1002/vzj2.20046","url":null,"abstract":"Seeking andmaintaining high editorial standards of scientific manuscripts is an important responsibility. This task can be accomplished only with the advice and input from a large number of colleagues who are invited to review submitted papers. Their critical comments and helpful suggestions have played amajor role inmakingVadose Zone Journal a success. Members of the VZJ Editorial Board want to express their appreciation to the following individuals who helped review manuscripts in 2019. We extend our apologies and thanks to any reviewer whose name may have been inadvertently omitted from this list.","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"153 1","pages":"9 - 9"},"PeriodicalIF":1.5,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/vzj2.20046","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44404229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacy Experience Pharmacie 2019: Thank you to sponsors","authors":"","doi":"10.1177/1715163519879409","DOIUrl":"https://doi.org/10.1177/1715163519879409","url":null,"abstract":"","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"152 1","pages":"433 - 433"},"PeriodicalIF":1.5,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163519879409","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41553166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Time for harmonization: Pharmacists as immunizers across Canadian jurisdictions","authors":"Joseph Fonseca, Jane Pearson Sharpe, S. Houle, N. Waite","doi":"10.1177/1715163519879179","DOIUrl":"https://doi.org/10.1177/1715163519879179","url":null,"abstract":"Background Improving vaccination coverage remains a global priority for reducing the health burden and social impact linked to at least 29 infectious diseases for which there are effective vaccines. While childhood vaccinations remain essential, an aging population means that the need for life-course vaccination programs that target adults is increasing. Pharmacists are particularly well suited to overcoming many of the challenges associated with vaccinating adult populations, hence the ongoing development of legislation for pharmacists as immunizers (PAIs) in Canada and abroad. This article provides an overview of the current Canadian landscape for pharmacists administering vaccines, highlights similarities and differences in legislation and regulation and discusses both challenges and opportunities for pharmacists who provide vaccination services. PAIs in Canada have expanded since 2007, when BC became the first province to allow pharmacist-administered vaccinations. Since that time, Canada’s decentralized pharmacy regulatory environment—where decision making takes place largely on a provincial/territorial (P/T) level—has resulted in P/T differences in how quickly and to what extent PAI authority has been implemented. The result is a heterogenous PAI landscape across Canadian jurisdictions, with several interacting variables determining which, if any, vaccines a pharmacist can administer, to whom and under what funding model.","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"152 1","pages":"395 - 400"},"PeriodicalIF":1.5,"publicationDate":"2019-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163519879179","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41336569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of pharmacists in providing recommended vaccines","authors":"Carlene Oleksyn","doi":"10.1177/1715163519877897","DOIUrl":"https://doi.org/10.1177/1715163519877897","url":null,"abstract":"In Canada, the National Advisory Committee on Immunization (NACI) makes recommendations for vaccination. However, vaccines that are publicly funded vary by province and territory, largely based on cost effectiveness and budget capacity, rather than clinical indication and vaccine effectiveness. Using their full scope of practice, pharmacists have a unique opportunity to offer recommended protection against vaccine-preventable diseases to patients.","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"152 1","pages":"406 - 410"},"PeriodicalIF":1.5,"publicationDate":"2019-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163519877897","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43250634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Opportunities for pharmacists in vaccinating higher-risk populations","authors":"Carolyn Whiskin, N. Cutcliffe","doi":"10.1177/1715163519877898","DOIUrl":"https://doi.org/10.1177/1715163519877898","url":null,"abstract":"1. Adults over 65 years of age 2. High-risk individuals with immunocompromising conditions, including those related to disease (such as cancer, human immunodeficiency virus [HIV] or sickle cell anemia), surgical procedures (such as tissue transplants or splenectomy) and immunosuppressive medications (biologic or nonbiologic therapies) 3. At-risk individuals who are immunocompetent but have 1 or more comorbid medical conditions, such as chronic heart disease, chronic obstructive pulmonary disease (COPD) or other chronic lung disease and diabetes","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"152 1","pages":"418 - 423"},"PeriodicalIF":1.5,"publicationDate":"2019-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163519877898","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43021206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Opportunities for pharmacists to recommend and administer routine vaccines","authors":"J. Isenor, S. Bowles","doi":"10.1177/1715163519878473","DOIUrl":"https://doi.org/10.1177/1715163519878473","url":null,"abstract":"The Canadian National Advisory Committee on Immunization (NACI) makes recommendations for the use of vaccines. Individual provinces and territories determine which vaccines will be funded and the schedules that are appropriate, based on their resources (e.g., funds, immunization providers, etc.). Routine vaccinations recommended for previously vaccinated adults and those who are unimmunized or underimmunized are found in Table 1. This article will focus on influenza, tetanus, diphtheria, acellular pertussis (Tdap) and tetanus and diphtheria (Td) vaccines for routine vaccination, as well as measles, mumps and rubella (MMR), meningococcal and polio vaccines for adults requiring catch-up, with emphasis on pharmacy-based vaccination. Other articles in this special section on pharmacists as immunizers give information on pneumococcal, human papillomavirus (HPV), varicella and zoster vaccines. Canadian pharmacists are highly accessible health care professionals. Approximately 60% of Ontarians reside within walking distance of a pharmacy and 91% within a 5 km drive, and similar results have been observed in Nova Scotia. This degree of accessibility and the resulting frequency of pharmacy visits (up to 14 times per year) provides pharmacists with multiple opportunities to assess for, recommend and administer routine vaccines for adults. However, there is considerable variation across provinces/territories regarding specific vaccines included within pharmacists’ scope of practice. Over 20 years ago, the American Pharmacists Association developed guidelines for pharmacy-based vaccination advocacy that are directly applicable to Canadian pharmacists today. Pharmacists were encouraged to engage their patients as educators (recommending vaccines), facilitators (hosting other immunizers in a pharmacy/clinic) or as immunizers. Evidence supports pharmacists in each of these roles to improve vaccination coverage among adult patients. Nowadays, vaccination is generally considered a standard of practice for pharmacists. In addition, community-based pharmacists are in an excellent position to determine if their adult patients are up to date on recommended vaccines. Medication reviews offer the opportunity to create an “inferred diagnosis” from current drug therapies, which can then be used to identify the need for education and/or specific vaccine recommendations. This might include influenza vaccine for patients receiving insulin, diabetic supplies or respiratory medications used to treat asthma or chronic obstructive pulmonary disease (COPD). Table 1 NACI-recommended routine vaccinations for previously immunized adults and for adults who are unimmunized or underimmunized","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"152 1","pages":"401 - 405"},"PeriodicalIF":1.5,"publicationDate":"2019-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163519878473","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46408762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cross-Canada updates","authors":"","doi":"10.1177/1715163519880474","DOIUrl":"https://doi.org/10.1177/1715163519880474","url":null,"abstract":"","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"152 1","pages":"430 - 432"},"PeriodicalIF":1.5,"publicationDate":"2019-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163519880474","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65467090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A brief overview of biosimilars and factors limiting their uptake","authors":"Nicholas Sosulski","doi":"10.1177/1715163519879411","DOIUrl":"https://doi.org/10.1177/1715163519879411","url":null,"abstract":"","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"152 1","pages":"364 - 366"},"PeriodicalIF":1.5,"publicationDate":"2019-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163519879411","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41934309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The impact of CPJ on practice: An update","authors":"J. Kung, J. Lipowski, R. Tsuyuki","doi":"10.1177/1715163519878659","DOIUrl":"https://doi.org/10.1177/1715163519878659","url":null,"abstract":"Over the past few years, we have been discussing the impact of CPJ on pharmacy practice. To recap, we view impact as how the material published in the journal affects practice (i.e., the patient care you deliver). Traditional measures of impact focus on citations (the number of times articles are cited by other authors)—we don’t think this is as relevant as changing your practice, which won’t be reflected by citations. As such, I am pleased to introduce Janice Kung, a health sciences librarian and new member of CPJ’s Editorial Board, and Jessica Lipowski, our publishing editor at SAGE Publications, who will be regularly reporting on the real impact of the journal.","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"152 1","pages":"357 - 361"},"PeriodicalIF":1.5,"publicationDate":"2019-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163519878659","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46343487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"How pharmacists are improving immunization in Canada","authors":"I. Gemmill","doi":"10.1177/1715163519878404","DOIUrl":"https://doi.org/10.1177/1715163519878404","url":null,"abstract":"","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"152 1","pages":"390 - 390"},"PeriodicalIF":1.5,"publicationDate":"2019-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163519878404","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46852655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}